Skip to content

Effect of TDCS in treatment of fibromyalgia

Comparison of the effectiveness of RTMS and TDCS in decreasing pain and improving quality of life in fibromyalgia patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20180220038802N1
Enrollment
30
Registered
2018-12-02
Start date
2018-01-25
Completion date
Unknown
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fibromyalgia. Fibromyalgia

Interventions

Intervention 1: Intervention group: Brain electrical stimulation using TDCS (Transcranial direct current stimulation)in left DLPFC (Dorsolateral prefrontal cortex) , which will be done by an experienc

Sponsors

Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: American college of rheumatology 's criteria for fibromyalgia Age >18 VAS >=4 (1week before study)

Exclusion criteria

Exclusion criteria: The patient desire to leave the study at each stage of the plan major depression ( beck score>30) or psychosis Diseases that disrupts the process ,such as diagnosed DM ,heart ,liver , pulmonary or kidney diseases Pregnancy and lactation Metal implant History of seizure or epilepsy

Design outcomes

Primary

MeasureTime frame
The severity of pain. Timepoint: Zero, The last day of treatment, 6 and 12 weeks later. Method of measurement: Visual analog scale (vas).;The quality of life. Timepoint: Zero ,6 and 12 weeks later. Method of measurement: By SF36 questionnare.;The depression and anxiety. Timepoint: Zero, 6 and 12 weeks later. Method of measurement: DASS questionnare.;Health condition in fibromyalgia. Timepoint: Zero, 6 and 12 weeks later. Method of measurement: FIQ questionnare.

Secondary

MeasureTime frame
Side effects. Timepoint: 6 and 12 weeks later. Method of measurement: Physical exam.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.Hosnie Haghighatshenas

Iran University of Medical Sciences

Hosnie64.Haq23@gmail.com+98 21 8214 1229

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026